StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Therapeutic Area Revenue Growth in USD by Quarter

Therapeutic Area Revenue Growth in USD (% USD) (%)

QuarterlyAnnual

Novartis Therapeutic Area Revenue Growth in USD: 23.0% in Q3 2026, down 8.0 pts from a year earlier.

Latest, Q3 2026
23.0%
Period ended Sep 30, 2026
Change on a year earlier
-8.0 pts
31.0% in Q3 2025
History
12 quarters
Since Q4 2023
Sources
12
Documents cited below

Where the Q3 2026 figure comes from

“|| Total neuroscience | 1 975 | 1 609 | 23 | 23”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTherapeutic Area Revenue Growth in USD (% USD) (%)Year on yearSource
Q3 2026Sep 30, 202623.0%-8.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202629.0%+10.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202620.0%-9.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202526.0%-4.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202531.0%+13.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202519.0%-22.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202529.0%-5.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202430.0%-2.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202418.0%–Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202441.0%–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202434.0%–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202332.0%–Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Therapeutic Area Revenue Growth in USD (%), quarterly Q4 2023–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/ta-neuroscience-yoy-usd-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.